Solvay SA SOLVAY ORD SHS/ BE0003470755 /
16/08/2024 18:36:51 | Chg. +0.03 | Volume | Bid16/08/2024 | Ask16/08/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
30.89EUR | +0.09% | 3,200 Turnover: 99,002.07 |
-Bid Size: - | -Ask Size: - | 3.24 bill.EUR | 7.87% | 1.54 |
GlobeNewswire
25/10/2023
NobleAI Announces Groundbreaking Collaboration with Microsoft Azure Quantum Elements
GlobeNewswire
12/10/2023
NobleAI’s Science-Based AI Technology to be Highlighted at SPE Annual Technical Conference and Expos...
GlobeNewswire
07/10/2023
CERN Inaugurates Science Gateway, Its New Outreach Centre for Science Education
GlobeNewswire
19/09/2023
Radix Engineering Expands US Operations, Appoints Alexander Clausbruch North America CEO
GlobeNewswire
07/09/2023
NobleAI Launches New AI-Powered Chemical and Materials Informatics Solutions on Microsoft’s Azure Ma...
GlobeNewswire
17/02/2022
Bluebell Capital Partners - Response to Solvay Board Open Letter Regarding Soda Ash Operations in Ro...
GlobeNewswire
11/01/2022
Western Rare Earths Announced as Team Member of the US Critical Materials Institute; Partner to DOE ...
GlobeNewswire
29/03/2021
Solvay’s Kadri will Present Keynote Lecture at AIChE’s Virtual Spring Meeting & Global Congress on P...
GlobeNewswire
01/10/2020
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer